Disparities in efficacy and safety of sodium-glucose cotransporter 2 inhibitor among patients with different extents of renal dysfunction: A systematic review and meta-analysis of randomized controlled trials

• Главные авторы: Suiyuan Hu (Автор), Chu Lin (Автор), Xiaoling Cai (Автор), Xingyun Zhu (Автор), Fang Lv (Автор), Wenjia Yang (Автор), Linong Ji (Автор)
• Формат: ‌
• Опубликовано: Frontiers Media S.A., 2022-11-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Background: The pleiotropic efficacy of SGLT2is in patients with different eGFR levels has not been well-understood. This systematic review and meta-analysis assessed the disparities in the efficacy and safety of SGLT2i treatment across stratified renal function.Methods: We searched four databases f...